Matches in Nanopublications for { ?s ?p "DDI between Etravirine and Brentuximab vedotin - Brentuximab, when used concomitantly with etravirine, may experience a decrease in serum concentrations. The levels of an active metabolite of brentuximab, monomethyl auristatin E, may decrease. It is recommended to monitor efficacy of brentuximab therapy."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB06414_DB08870 title "DDI between Etravirine and Brentuximab vedotin - Brentuximab, when used concomitantly with etravirine, may experience a decrease in serum concentrations. The levels of an active metabolite of brentuximab, monomethyl auristatin E, may decrease. It is recommended to monitor efficacy of brentuximab therapy." assertion.